May 1, 2017 – Having cleared the Senate Committee on Health, Education, Labor and Pensions (HELP) with a 14-9 vote on April 27, Dr. Scott Gottlieb’s nomination to be the next FDA commissioner is now headed for a full Senate vote. So far, Gottlieb’s nomination has moved quickly and smoothly through the nomination process. “Gottlieb […]
Read moreTag: marketing
marketingLeveraging Technology and Other Highlights from DIA Marketing Meeting
Feb. 23, 2015 – Dale Cooke, owner of PhillyCooke Consulting, who spoke Feb. 18 at the Drug Information Association’s Marketing Pharmaceuticals conference, told attendees that because mobile use for health information has exploded, they should be leveraging innovative technologies to reach users where they are. To view a summary of Cooke’s presentation and read his […]
Read moreSunshine Act Data Could Increase FDA’s Ability to Prosecute Marketing Violations
June 14, 2013 – The data collected under the Physician Payments Sunshine Act will be part of a database that the FDA’s Office of Criminal Investigations (OCI) is building to detect potentially fraudulent activity, including off-label marketing violations, according to a June 11 article in Policy and Medicine. The OCI “recently issued a solicitation notice […]
Read moreUPDATE: Supreme Court finds Rx data use ban violates the First Amendment
June 23, 2011 — Justices find Vermont violated First Amendment rights of pharma and data publishers Sweeping aside justifications by the state of Vermont and privacy advocates, the United States Supreme Court today found the Vermont ban on marketing use of Rx data a violation of the First Amendment. ” This is a victory for patients as […]
Read moreHow Will ACOs Affect Drug Sales?
From PharmExec.com: April 7, 2011 — In the April 5 microsoft oem software issue of PharmExec.com, the author raises the issue of whether Accountable Care Organizations (ACOs) will alter prescription drug business, and states that pharmaceutical companies hoping to do business with ACOs “will have to show that expensive brand drugs can offer not just […]
Read moreCall for Do Not Track Legislation Intensifies at Senate Hearing
Obama Administration Says Legislation Would Provide “Firm Legal Foundation” March 17, 2011 — Current industry self-regulation on digital tracking and marketing practices may not be enough to stave off legislation establishing a mandatory Do Not Track program, according to testimony and remarks made at a Senate Commerce, Science & Transportation Committee hearing held March 16 […]
Read moreFederal Regulators Send Clear Message to Digital Marketers: Self-regulate Now or Be Regulated
March 11, 2011 — As the public debate over digital privacy continues, federal regulators on and off Capitol Hill are telling online marketers that now is the time to widely adopt strict self regulatory programs that enable Web users to opt-out of unwanted tracking and marketing. If not, marketers can expect legislation and/or regulation by […]
Read moreRough Seas or Smooth Sailing? Navigating Pharma’s Role in Social Media Marketing
Feb. 14, 2011 — As more and more pharmaceutical companies explore the addition or expansion of social media marketing efforts, they are seeking to balance the perceived benefits of such marketing with the slow emergence of metrics to validate those benefits. However, it appears that social media marketing is gaining traction, according to a recent Harvard […]
Read more
General
Coalition Focus for 2011
Coalition Focus for 2011
Although 2011 brings political party shifts in Congress and new challenges, the mission of the Coalition for Healthcare Communication (CHC) remains the same: To protect, for society and individual patients, the benefit of the free flow of healthcare information. This year the CHC will be focusing on four major issues: (1) tax treatment of marketing […]
Read moreRichard Myer: A HCP's Response to the PLoS Study That Pharma Marketing Increases Rx's
From : The PLoS study reveals the obvious: pharmaceutical marketing affects prescribing. Pharma would not spend all diflucan sale the money they do on marketing if it didn’t work. In addition, they have a fiduciary responsibility to their shareholders to make providers (and some might argue the public) aware of their products. how to save […]
Read more